查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032366

非處方胃腸道藥物市場：按藥物類別、適應症、最終用戶和地區分類（2026-2034 年）

Gastrointestinal OTC Drugs Market by Drug Class, Indication (Gastroesophageal Reflux Disease or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球非處方（成藥市場規模達453億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到633億美元，2026年至2034年的複合年成長率為3.66%。胃腸道疾病盛行率的上升、公眾對胃腸道健康的日益重視以及先進製劑的最新進展是推動市場成長的主要因素。

非處方（成藥是處方箋無需處方即可購買的藥物，用於緩解胃腸道症狀並促進整體消化器官系統健康。這些藥物包括瀉藥、制酸劑、H2受體阻斷劑、質子幫浦阻斷劑（PPI）、止吐藥、腸道抗發炎藥和止瀉。成藥消化器官系統藥物廣泛用於治療消化不良、便秘、灼熱、腹瀉、暈動病、胃酸逆流、噁心、大腸激躁症（IBS）和腹痛。它們價格實惠、使用方便且易於獲取，能夠快速緩解症狀，提高患者舒適度，並有助於患者自我管理。成藥也有助於改善腸道環境，恢復有益菌叢，預防併發症，並減輕疼痛、腹脹、腹部不適和嘔吐等各種症狀的嚴重程度。

非處方（成藥市場趨勢：

久坐不動的生活方式和不健康的飲食習慣導致胃腸道疾病日益普遍，這是推動市場成長的主要因素。非處方（成藥廣泛用於治療感染疾病、消化不良、急性腹瀉、胃灼熱、胃食道逆流（GERD）、便秘、腹脹和孕吐。此外，大眾對消化器官系統健康的日益重視，促使越來越多的產品湧現，旨在改善消化、促進腸道健康、確保營養物質的正確分解和吸收，從而推動市場成長。同時，注重自我護理和消費者自主管理自身健康、預防未來健康併發症的新趨勢也正在推動市場成長。此外，發泡、液體、懸浮液、薄膜衣片和咀嚼片等先進製劑的最新進展，透過提高藥物療效、改善吸收率和減少給藥頻率，也對市場成長產生了積極影響。便捷便攜包裝的推出，例如泡殼包裝、可重複密封袋和單劑量包裝，也促進了市場成長。此外，消費者對非侵入性治療方法的偏好日益成長，推動了對能夠緩解常見消化器官系統問題並提供即時療效的產品的需求。同時，多家製造商透過電視廣告、社群媒體、網紅行銷和名人代言等管道所進行的積極推廣和品牌宣傳宣傳活動，也促進了市場成長。預計推動市場成長的其他因素還包括老年人口的成長、消費者購買力的提升以及透過電子商務平台便捷購買產品。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球非處方胃腸道藥物市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依藥物類別分類

  • 瀉藥
  • 胃腸道癌症的治療
  • 胃酸分泌抑制劑
  • 止瀉
  • 質子幫浦阻斷劑
  • H2抑制劑
  • 解毒劑
  • 腸道抗發炎藥物
  • 止吐藥

第7章 市場區隔：依適應症分類

  • 胃食道逆流（GERD）或胃灼熱
  • 便秘
  • 腹瀉
  • 暈動病
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Boehringer Ingelheim GmbH
    • Johnson & Johnson
    • Prestige Consumer Healthcare Inc.
    • Purdue Pharma LP
    • Sanofi
    • Zydus Lifesciences Limited
Product Code: SR112026A7781

The global gastrointestinal OTC drugs market size reached USD 45.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 63.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.66% during 2026-2034. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.

Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.

GASTROINTESTINAL OTC DRUGS MARKET TRENDS:

The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.

KEY MARKET SEGMENTATION:

Drug Class Insights:

  • Laxatives
  • Gastrointestinal Cancer Treatments
  • Gastric Acid Reducers
  • Anti-Diarrheal
  • Proton Pump Inhibitors
  • H2 Inhibitors
  • Gastric Acid Neutralizers
  • Bowel Anti-Inflammatory
  • Anti-Emetics

Indication Insights:

  • Gastroesophageal Reflux Disease (GERD) or Heartburn
  • Constipation
  • Diarrhea
  • Motion Sickness
  • Others

End User Insights:

  • Hospitals
  • Clinics
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gastrointestinal OTC Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Laxatives
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gastrointestinal Cancer Treatments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gastric Acid Reducers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Anti-Diarrheal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Proton Pump Inhibitors
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 H2 Inhibitors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Gastric Acid Neutralizers
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Bowel Anti-Inflammatory
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Anti-Emetics
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Gastroesophageal Reflux Disease (GERD) or Heartburn
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Constipation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Motion Sickness
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Prestige Consumer Healthcare Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Purdue Pharma L.P
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Sanofi
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Zydus Lifesciences Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2025
  • Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2025
  • Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2025
  • Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
  • Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2026-2034
  • Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
  • Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players